NextGen sales double in 1H07, operating losses reduced

NextGen Group plc, the Cambridge-based "gene-to-protein" company, reported that sales increase increased 128% to £1.07m in the six months ended 30th June. Operating loss was lower at £1.26m, compared with £1.34m in 2006.

Chairman Anthony Rhatigan (pictutred) said the trend of increased revenues had contiued since the initial flotation of the Company in late 2005.

“From a period of uncertainty at this time last year we have seen an increasing confidence among our pharmaceutical and biotechnology clients and there have been sales of both expressionworkstation and baculoworkstation.

“In addition, the trend to outsource more parts of the drug development process by the large pharmaceutical and biotechnology companies has continued and the Company has benefitted greatly from that in both the number of clients we service and an increasing value of contracts on repeat business.

“The business of NextGen has evolved from being primarily a supplier of expert systems in the proteomics market to a company that has three distinct and growing revenue streams. These are, the original equipment business, the fee for service business and the expert IT business that has grown around the Company's novel rules engine orchestratorIMS that drives its various proteomics systems.

“NextGen continues to build its sales team in order speed up the full commercialisation of its range of products. During this period we have appointed a locally-based sales person for mainland Europe to complement the European team based in Cambridge.

“The fee-for-service business continues to show good promise for growth particularly in the US where the training of the sales team has now been completed. The team are making good progress in raising awareness of NextGen's equipment portfolio and are expecting to secure some important orders during the coming months. In addition, we have seen significant growth in the sales of the optigel range of pre-cast electrophoresis gels. During the period, we have also released an update of orchestratorIMS which has been received very favourably by existing users as well as those organisations that are considering its installation.”

28th September 2007


Previous articles
Briefs: Sareum boosted by Johnson & Johnson contract extension; NXT’s flat speakers into another Citreon
Cambridge Uni starts search for a new Vice-Chancellor
Listed Silicon Fenners show cause for celebration, and concern
Plasmon’s restructure at ‘advanced stage’; flags £3.7m one-off loss, ’07 pre-tax loss of £15m ahead of share placment
Private investment in stem cell research stalled; patent applications in China soar: Marks & Clerk
Celsis says business momentum continued in 3Q08
NXT disappoints stock market despite halving pre-tax losses in FY07/08
Acambis surprised as US Govt rejects smallpox vaccine proposal
ANT product shipments jump as losses widen; broadening offerings
CSR hits record revenue in H1 2007; sees double digit yearly growth to 2012
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Peters Elworthy & Moore


Lake Falconer
Head of Corporate Finance


Peters Elworthy & Moore is an independent Cambridge-based firm of chartered accountants and chartered tax advisors with 15 partners and over 130 staff. It provides a comprehensive list of services from auditing and accounting through tax consultancy, business recovery, corporate finance, IT, HR and

[Peters Elworthy & Moore's profile]


Top20 Index




Currently: 161